- Home
- BLCO vs MMSI Comparison
BLCO vs MMSI Comparison
Compare BLCO & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- MMSI
- Stock Information
- Founded
- BLCO 1853
- MMSI 1987
- Country
- BLCO Canada
- MMSI United States
- Employees
- BLCO N/A
- MMSI N/A
- Industry
- BLCO Ophthalmic Goods
- MMSI Medical/Dental Instruments
- Sector
- BLCO Health Care
- MMSI Health Care
- Exchange
- BLCO Nasdaq
- MMSI Nasdaq
- Market Cap
- BLCO 7.0B
- MMSI 5.8B
- IPO Year
- BLCO 2022
- MMSI 1990
- Fundamental
- Price
- BLCO $19.67
- MMSI $105.06
- Analyst Decision
- BLCO Buy
- MMSI Buy
- Analyst Count
- BLCO 11
- MMSI 10
- Target Price
- BLCO $21.30
- MMSI $103.70
- AVG Volume (30 Days)
- BLCO 477.2K
- MMSI 443.5K
- Earning Date
- BLCO 10-30-2024
- MMSI 10-30-2024
- Dividend Yield
- BLCO N/A
- MMSI N/A
- EPS Growth
- BLCO N/A
- MMSI 19.39
- EPS
- BLCO N/A
- MMSI 2.05
- Revenue
- BLCO $4,684,000,000.00
- MMSI $1,325,871,000.00
- Revenue This Year
- BLCO $17.44
- MMSI $9.36
- Revenue Next Year
- BLCO $6.18
- MMSI $9.09
- P/E Ratio
- BLCO N/A
- MMSI $51.07
- Revenue Growth
- BLCO 18.01
- MMSI 8.12
- 52 Week Low
- BLCO $13.16
- MMSI $65.46
- 52 Week High
- BLCO $21.69
- MMSI $105.46
- Technical
- Relative Strength Index (RSI)
- BLCO 44.49
- MMSI 61.14
- Support Level
- BLCO $19.31
- MMSI $100.60
- Resistance Level
- BLCO $20.23
- MMSI $104.75
- Average True Range (ATR)
- BLCO 0.48
- MMSI 2.08
- MACD
- BLCO -0.13
- MMSI 0.18
- Stochastic Oscillator
- BLCO 5.48
- MMSI 73.72
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About MMSI Merit Medical Systems Inc.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.